☆ 4.7 Editorial Material

Donanemab for Alzheimer Disease-Who Benefits and Who Is Harmed?

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Journal

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Volume 330, Issue 6, Pages 510-511

Publisher

AMER MEDICAL ASSOC

DOI: 10.1001/jama.2023.11704

Keywords

-

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.